Blue light even at longer wavelengths shows antifibrotic activity and may represent a suitable and safe approach in the treatment of fibrotic skin diseases including hypertrophic scarring and scleroderma. Link to abstract
The impact of non-toxic blue light (453 nm) on cellular antioxidative capacity, TGF-β1 signaling, and myofibrogenesis of human skin fibroblasts
Blue light even at longer wavelengths shows antifibrotic activity and may represent a suitable and safe approach in the treatment of fibrotic skin diseases including hypertrophic scarring and scleroderma. View abstract
PHLECS winner of the EIT Health’s Bridgehead Global program 2020
Dutch MedTech start-up PHLECS has just been selected by EIT Health to participate in its Bridgehead Global program. After receiving the CE marking for its Full Body Blue Light device last March, PHLECS is now moving forward to its next business milestone ...
PHLECS, a Dutch start-up that launches a new drug-free therapy for psoriasis
The Dutch MedTech start-up has just obtained the medical CE marking for the Full Body Blue Light Device and will start its commercialization in Europe from April 2020 onwards. Press release
Blue light (λ=453 nm) nitric oxide dependently induces β-endorphin production of human skin keratinocytes in-vitro and increases systemic β- endorphin levels in humans in-vivo
The described blue light-induced effects that are mediated by bioactive NO-derivates bear a relevant clinical potential to serve as supportive measure in the therapy of several psychiatric disorders. Additionally, due to the positive influence of β-endo ...